FIND extends partnership with 42T for TB and malaria tests

The Foundation for Innovative New Diagnostics (FIND) has confirmed an extension to its existing development partnership with 42 Technology (42T). FIND is driving the development and early implementation of diagnostic tests for tuberculosis (TB), malaria and other diseases.

The consultancy has been appointed to work on a number of diagnostic projects involving the development of very low cost and more effective tests that are simple and robust enough to be used in challenging locations and closer to patients.

The work will primarily benefit detection and screening initiatives for the control and treatment of TB and malaria.